Page last updated: 2024-09-05

sorafenib and amygdalin

sorafenib has been researched along with amygdalin in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(amygdalin)
Trials
(amygdalin)
Recent Studies (post-2010) (amygdalin)
6,5207305,25166322193

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Attia, AA; El-Magd, MA; El-Naggar, SA; Eldiasty, JG; Elmetwalli, A; Mosallam, SAE; Nasser, HM; Salama, AF1

Other Studies

1 other study(ies) available for sorafenib and amygdalin

ArticleYear
Amygdalin potentiates the anti-cancer effect of Sorafenib on Ehrlich ascites carcinoma and ameliorates the associated liver damage.
    Scientific reports, 2022, 04-20, Volume: 12, Issue:1

    Topics: Amygdalin; Animals; Antioxidants; Ascites; Carcinoma, Ehrlich Tumor; Liver; Matrix Metalloproteinase 9; Mice; Neoplasms; NF-E2-Related Factor 2; Sorafenib; Superoxide Dismutase; Vascular Endothelial Growth Factor A

2022